NKTR : Nektar Therapeutics stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-09-27 |
|---|---|---|---|---|
| 2023 | $0.59 | $0.58 | $0.6 | -2.06% |
| 2024 | $2.0 | $0.7 | $3.34 | 231.76% |
| 2025 | $4.25 | $3.44 | $4.76 | 606.83% |
| 2026 | $3.56 | $3.41 | $3.81 | 491.75% |
| 2027 | $4.4 | $3.95 | $4.59 | 631.14% |
| 2028 | $4.5 | $4.45 | $4.53 | 647.51% |
| 2029 | $3.91 | $3.47 | $4.5 | 548.93% |
| 2030 | $4.61 | $4.24 | $4.81 | 665.98% |
| 2031 | $2.8 | $2.22 | $4.0 | 364.81% |
| 2032 | $5.47 | $3.27 | $6.7 | 808.34% |
| 2033 | $5.29 | $3.38 | $6.6 | 779.02% |
The 2 Wall Street analysts offering Nektar Therapeutics stock forecast in the last 6 months have average price target of
$3.5 with a high forecast of $6.0 and a low forecast of $1.0.
The average Nektar Therapeutics stock forecast represents a 481.59%
increase from the last price of $0.60180002450943.
From AI system, total return is 2366.52% from 4098 forecasts.
For Nektar Therapeutics stock forecast for 2023, 3 predictions are offered for each month of 2023 with average Nektar Therapeutics stock
forecast of $0.59, a high forecast of $0.6, and a low forecast of $0.58.
The average Nektar Therapeutics stock forecast 2023 represents a -2.06%
decrease from the last price of $0.60180002450943.
For Nektar Therapeutics stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Nektar Therapeutics stock
forecast of $2.0, a high forecast of $3.34, and a low forecast of $0.7.
The average Nektar Therapeutics stock forecast 2024 represents a 231.76%
increase from the last price of $0.60180002450943.
For Nektar Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Nektar Therapeutics stock
forecast of $3.56, a high forecast of $3.81, and a low forecast of $3.41.
The average Nektar Therapeutics stock forecast 2026 represents a 491.75%
increase from the last price of $0.60180002450943.
For Nektar Therapeutics stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Nektar Therapeutics stock
forecast of $4.5, a high forecast of $4.53, and a low forecast of $4.45.
The average Nektar Therapeutics stock forecast 2028 represents a 647.51%
increase from the last price of $0.60180002450943.
For Nektar Therapeutics stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Nektar Therapeutics stock
forecast of $2.8, a high forecast of $4.0, and a low forecast of $2.22.
The average Nektar Therapeutics stock forecast 2031 represents a 364.81%
increase from the last price of $0.60180002450943.
For Nektar Therapeutics stock forecast for 2033 (10 year), 9 predictions are offered for each month of 2033 with average Nektar Therapeutics stock
forecast of $5.29, a high forecast of $6.6, and a low forecast of $3.38.
The average Nektar Therapeutics stock forecast 2033 represents a 779.02%
increase from the last price of $0.60180002450943.
Please, see more forecasts below.
NKTR : Nektar Therapeutics stock forecast by Wall Street Analysts
The average Nektar Therapeutics stock forecast from last 6 month is $3.5, and this show a -33.33% decrease in average from the prior price target of the each prediction. Also, this average forecast of $3.5 represents a 47.06% increase from the past average forecast of $2.38, 6 months ago from 4 wall street analysts.
Nektar Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-09-29 | $.61 | 1.84% |
| 2023-10-02 | $.61 | -0.94% |
| 2023-10-03 | $.62 | 2.13% |
| 2023-10-04 | $.64 | 2.65% |
| 2023-10-05 | $.64 | 0.14% |
NKTR : Long term Nektar Therapeutics stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Oct. is $.59 , for 2024 Sep. is $2.77 , for 2027 Sep. is $4.50 , for 2028 Sep. is $4.53 , for 2032 Sep. is $6.30 , and for 2033 Sep. is $3.38.
NKTR : Nektar Therapeutics stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Oct. | $.59 | -2.08% |
| 2023 Nov. | $.58 | -1.79% |
| 2023 Dec. | $.60 | 3.70% |
NKTR : Nektar Therapeutics stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $.70 | 16.89% |
| 2024 Feb. | $.85 | 21.60% |
| 2024 Mar. | $1.03 | 20.39% |
| 2024 Apr. | $1.23 | 20.15% |
| 2024 May. | $1.48 | 20.06% |
| 2024 Jun. | $1.79 | 20.64% |
| 2024 Jul. | $2.09 | 17.18% |
| 2024 Aug. | $2.42 | 15.44% |
| 2024 Sep. | $2.77 | 14.57% |
| 2024 Oct. | $3.03 | 9.56% |
| 2024 Nov. | $3.22 | 6.20% |
| 2024 Dec. | $3.34 | 3.59% |
NKTR : Nektar Therapeutics stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $3.44 | 3.11% |
| 2025 Feb. | $3.61 | 4.76% |
| 2025 Mar. | $3.89 | 7.88% |
| 2025 Apr. | $4.24 | 9.01% |
| 2025 May. | $4.56 | 7.53% |
| 2025 Jun. | $4.76 | 4.30% |
| 2025 Jul. | $4.76 | 0.20% |
| 2025 Aug. | $4.68 | -1.74% |
| 2025 Sep. | $4.54 | -3.04% |
| 2025 Oct. | $4.37 | -3.64% |
| 2025 Nov. | $4.20 | -4.03% |
| 2025 Dec. | $4.00 | -4.81% |
NKTR : Nektar Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $3.81 | -4.72% |
| 2026 Feb. | $3.65 | -4.15% |
| 2026 Mar. | $3.54 | -3.06% |
| 2026 Apr. | $3.46 | -2.15% |
| 2026 May. | $3.43 | -0.97% |
| 2026 Jun. | $3.41 | -0.57% |
| 2026 Jul. | $3.42 | 0.21% |
| 2026 Aug. | $3.45 | 0.97% |
| 2026 Sep. | $3.51 | 1.74% |
| 2026 Oct. | $3.59 | 2.26% |
| 2026 Nov. | $3.68 | 2.60% |
| 2026 Dec. | $3.80 | 3.35% |
NKTR : Nektar Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $3.95 | 3.94% |
| 2027 Feb. | $4.11 | 4.03% |
| 2027 Mar. | $4.23 | 2.92% |
| 2027 Apr. | $4.39 | 3.76% |
| 2027 May. | $4.55 | 3.55% |
| 2027 Jun. | $4.59 | 0.92% |
| 2027 Jul. | $4.55 | -0.82% |
| 2027 Aug. | $4.51 | -0.91% |
| 2027 Sep. | $4.50 | -0.30% |
| 2027 Oct. | $4.49 | -0.23% |
| 2027 Nov. | $4.47 | -0.45% |
| 2027 Dec. | $4.45 | -0.31% |
NKTR : Nektar Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $4.45 | -0.04% |
| 2028 Feb. | $4.46 | 0.11% |
| 2028 Mar. | $4.47 | 0.22% |
| 2028 Apr. | $4.48 | 0.27% |
| 2028 May. | $4.49 | 0.29% |
| 2028 Jun. | $4.51 | 0.32% |
| 2028 Jul. | $4.52 | 0.34% |
| 2028 Aug. | $4.53 | 0.18% |
| 2028 Sep. | $4.53 | -0.01% |
| 2028 Oct. | $4.52 | -0.10% |
| 2028 Nov. | $4.52 | -0.12% |
| 2028 Dec. | $4.51 | -0.17% |
NKTR : Nektar Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $4.50 | -0.35% |
| 2029 Feb. | $4.46 | -0.87% |
| 2029 Mar. | $4.33 | -2.83% |
| 2029 Apr. | $4.04 | -6.76% |
| 2029 May. | $3.67 | -9.04% |
| 2029 Jun. | $3.47 | -5.57% |
| 2029 Jul. | $3.59 | 3.64% |
| 2029 Aug. | $3.59 | -0.21% |
| 2029 Sep. | $3.61 | 0.61% |
| 2029 Oct. | $3.70 | 2.68% |
| 2029 Nov. | $3.86 | 4.21% |
| 2029 Dec. | $4.05 | 4.88% |
NKTR : Nektar Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $4.24 | 4.81% |
| 2030 Feb. | $4.42 | 4.04% |
| 2030 Mar. | $4.54 | 2.74% |
| 2030 Apr. | $4.61 | 1.71% |
| 2030 May. | $4.67 | 1.27% |
| 2030 Jun. | $4.73 | 1.19% |
| 2030 Jul. | $4.78 | 1.12% |
| 2030 Aug. | $4.81 | 0.64% |
| 2030 Sep. | $4.80 | -0.17% |
| 2030 Oct. | $4.75 | -1.16% |
| 2030 Nov. | $4.61 | -2.98% |
| 2030 Dec. | $4.35 | -5.59% |
NKTR : Nektar Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $4.00 | -8.02% |
| 2031 Feb. | $3.64 | -9.12% |
| 2031 Mar. | $3.32 | -8.74% |
| 2031 Apr. | $3.05 | -8.15% |
| 2031 May. | $2.81 | -7.70% |
| 2031 Jun. | $2.60 | -7.48% |
| 2031 Jul. | $2.42 | -7.04% |
| 2031 Aug. | $2.29 | -5.49% |
| 2031 Sep. | $2.22 | -2.82% |
| 2031 Oct. | $2.22 | -0.11% |
| 2031 Nov. | $2.33 | 5.13% |
| 2031 Dec. | $2.67 | 14.28% |
NKTR : Nektar Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $3.27 | 22.76% |
| 2032 Feb. | $4.13 | 26.12% |
| 2032 Mar. | $4.92 | 19.27% |
| 2032 Apr. | $5.32 | 8.12% |
| 2032 May. | $5.24 | -1.61% |
| 2032 Jun. | $5.29 | 0.96% |
| 2032 Jul. | $5.38 | 1.73% |
| 2032 Aug. | $5.72 | 6.40% |
| 2032 Sep. | $6.30 | 10.09% |
| 2032 Oct. | $6.62 | 5.06% |
| 2032 Nov. | $6.70 | 1.27% |
| 2032 Dec. | $6.68 | -0.31% |
NKTR : Nektar Therapeutics stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $6.60 | -1.31% |
| 2033 Feb. | $6.43 | -2.51% |
| 2033 Mar. | $6.20 | -3.63% |
| 2033 Apr. | $5.98 | -3.51% |
| 2033 May. | $5.72 | -4.32% |
| 2033 Jun. | $5.13 | -10.34% |
| 2033 Jul. | $4.37 | -14.77% |
| 2033 Aug. | $3.80 | -13.20% |
| 2033 Sep. | $3.38 | -10.88% |
Frequently Asked Questions about Nektar Therapeutics stock forecast
Is Nektar Therapeutics a good long term stock?
From Nektar Therapeutics stock forecast , Nektar Therapeutics (NKTR) stock cannot be a good investment choice. According to Tudal, the Nektar Therapeutics stock price forecast for 2023 Oct. is $0.589278636626886 From Nektar Therapeutics stock forecast , Nektar Therapeutics (NKTR) stock can be a good investment choice. According to Tudal, the Nektar Therapeutics stock price forecast for 2024 Sep. is $2.76935135280773 From Nektar Therapeutics stock forecast , Nektar Therapeutics (NKTR) stock can be a good investment choice. According to Tudal, the Nektar Therapeutics stock price forecast for 2027 Sep. is $4.49741498573039 From Nektar Therapeutics stock forecast , Nektar Therapeutics (NKTR) stock can be a good investment choice. According to Tudal, the Nektar Therapeutics stock price forecast for 2028 Sep. is $4.52887876179959 From Nektar Therapeutics stock forecast , Nektar Therapeutics (NKTR) stock can be a good investment choice. According to Tudal, the Nektar Therapeutics stock price forecast for 2032 Sep. is $6.30230283421584 From Nektar Therapeutics stock forecast , Nektar Therapeutics (NKTR) stock can be a good investment choice. According to Tudal, the Nektar Therapeutics stock price forecast for 2033 Sep. is $3.38224362353965
Is Nektar Therapeutics stock overvalued?
Nektar Therapeutics (NKTR) stock is expected to go UP . Therefore, Tudal would say that Nektar Therapeutics (NKTR) stock is NOT overvalued.
Will Nektar Therapeutics stock price go up?
Yes. The Nektar Therapeutics stock price forecast for 2024 Sep. is $2.76935135280773
Is Nektar Therapeutics stock a good buy now?
Since closing price on 2023-09-27 is $0.60180002450943 and forecast for 2024 Sep. is $2.77, Nektar Therapeutics stock is a good 1 year investment.